glp 1 average weekly weight loss GLP-1 Agonists Drugs Market Report, 2025-2030 New oral GLP-1 drug delivers

Body measurements tell a comprehensive story

Patients were asked about their experience with GLP-1 usage, and the responses were analyzed to find the biggest trends among users

Five or six years after it was first released, it was a drug that was certainly not cost prohibitive for anyone with insurance

Semaglutide a game changer Semaglutide is the GLP-1 agonist that was approved in June 2021

Although, anecdotally, it is no secret that Mounjaro is already being prescribed to patients without T2D for weight loss and the comorbidity of T2D and obesity blurs the line, once Mounjaro is approved I believe it will begin reducing the average out of pocket costs for these drugs